Pos1133 Treatment of Systemic Lupus Erythematosus Patients With Upadacitinib Results in the Coordinated Inhibition of Type 1 Ifn-related Biomarkers: Biomarker Analysis of the M19-130 (sleek) Phase 2 Study
Year: 2023
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: M.C. Gaudreau, J. Fann, S. Contrepois, A. Friedman, T. Sornasse, J.T. Merrill
Institutions: AbbVie (United States), Oklahoma Medical Research Foundation
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4379650091